Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05702749 · ClinicalTrials.gov registry record · NA
Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas
A NA study of Vestibular Schwannoma, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05702749: Recruiting NA study of Vestibular Schwannoma, sponsored by Medical College of Wisconsin.
NCT05702749 is a NA study of Vestibular Schwannoma that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 36 participants, below the 47-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05702749, a NA study of Vestibular Schwannoma, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patients undergoing pretreatment rehab (PREHAB) or no PREHAB when managed with either surgery or radiosurgery.
Primary Outcome
The sensory organization test (SOT) was developed to describe the contribution levels of the three basic systems of balance (visual, vestibular, somatosensory) to the general equilibrium. The primary endpoint is the SOT at post-treatment assessments. This is measured by a composite score. A higher score equals greater stability. The measurement is made by a Bertec machine.
Conditions Studied
Interventions
- PROCEDURE Microsurgical resection of VS
- RADIATION Stereotactic radiosurgery
- OTHER PREHAB
Study Locations (1)
Wisconsin
- Froedtert Hospital and the Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT05702749 shows while recruiting
NCT05702749 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 47-participant average among 7 other Vestibular Schwannoma trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Vestibular Schwannoma appearing as the primary indexed condition, and to 3 interventions - of which Microsurgical resection of VS is the first listed.
NCT05702749 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05702749 about?
NCT05702749 is a clinical study titled "Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients with Vestibular Schwannomas". The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patients undergoing pretreatment rehab (PREHAB) or no PREHAB when managed with either surgery or radiosurgery.
What is the current status of trial NCT05702749?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-01-22. Estimated completion is 2027-12.
What conditions does trial NCT05702749 study?
This clinical trial studies the following conditions: Vestibular Schwannoma.
What interventions are being tested in trial NCT05702749?
The interventions under investigation include: Microsurgical resection of VS (PROCEDURE), Stereotactic radiosurgery (RADIATION), PREHAB (OTHER).
Who is sponsoring clinical trial NCT05702749?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05702749 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vestibular Schwannoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
StableEyes With Active Neurofeedback
RECRUITING · NA
-
CI Following VS Removal or Labyrinthectomy
RECRUITING · NA
-
Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma
RECRUITING · Phase 1
-
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
-
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
ACTIVE NOT RECRUITING · Phase 2
-
Study of Aspirin in Patients With Vestibular Schwannoma
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI